Morning Overview on MSN
Weight-loss drugs like Ozempic may also raise the risk of arthritis, a large study finds
Millions of people now take GLP-1 receptor agonist drugs such as semaglutide and liraglutide for diabetes and weight loss. A ...
The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging ...
The proportion of adults in the US taking GLP-1 medications for weight loss has reached a record high of about 40 million people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results